Skip to main content
SpringerLink
Log in

Molecular Pathology of Hemoglobin and Erythrocyte Membrane Disorders

  • Chapter
  • First Online:
Molecular Pathology of Hematolymphoid Diseases

Part of the book series: Molecular Pathology Library ((MPLB,volume 4))

  • 1365 Accesses

Abstract

Inherited abnormalities of the erythrocyte comprise an important group of hemolytic disorders. These defects include abnormal hemoglobins and abnormal proteins of the erythrocyte membrane. Because of the easy accessibility of the erythrocyte, these disorders represent some of the best understood disorders at the molecular level. A logical approach to the evaluation and diagnosis of these disorders allows implementation of rational management strategies and the avoidance of ineffective or deleterious therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Angastiniotis M, Modell B, Englezos P, Boulyjenkov V. Prevention and control of haemoglobinopathies. Bull World Health Organ. 1995;73:375–386.

    CAS  PubMed  Google Scholar 

  2. Weatherall DJ, Clegg JB. Thalassemia – a global public health problem. Nat Med. 1996;2:847–849.

    Article  CAS  PubMed  Google Scholar 

  3. Angastiniotis M, Modell B. Global epidemiology of hemoglobin disorders. Ann N Y Acad Sci. 1998;850:251–269.

    Article  CAS  PubMed  Google Scholar 

  4. Chui DH, Waye JS. Hydrops fetalis caused by alpha-thalassemia: an emerging health care problem. Blood. 1998;91:2213–2222.

    CAS  PubMed  Google Scholar 

  5. Heer N, Choy J, Vichinsky EP. The social impact of migration on disease. Cooley’s anemia, thalassemia, and new Asian immigrants. Ann N Y Acad Sci. 1998;850:509–511.

    Article  CAS  PubMed  Google Scholar 

  6. Lorey F. Asian immigration and public health in California: thalassemia in newborns in California. J Pediatr Hematol Oncol. 2000;22:564–566.

    Article  CAS  PubMed  Google Scholar 

  7. Old JM. Screening and genetic diagnosis of haemoglobinopathies. Scand J Clin Lab Invest. 2007;67:71–86.

    Article  CAS  PubMed  Google Scholar 

  8. Pearson HA, Cohen AR, Giardina PJ, Kazazian HH. The changing profile of homozygous beta-thalassemia: demography, ethnicity, and age distribution of current North American patients and changes in two decades. Pediatrics. 1996;97:352–356.

    CAS  PubMed  Google Scholar 

  9. Vichinsky EP, MacKlin EA, Waye JS, Lorey F, Olivieri NF. Changes in the epidemiology of thalassemia in North America: a new minority disease. Pediatrics. 2005;116:e818–e825.

    Article  PubMed  Google Scholar 

  10. Stamatoyannopoulos G, Grosveld F. Hemoglobin switching. In: Stamatoyannopoulos G, Majerus PW, Perlmutter RM, Varmus H, eds. The Molecular Basis of Blood Diseases. Philadelphia: W. B. Saunders; 2001.

    Google Scholar 

  11. Stamatoyannopoulos G. Control of globin gene expression during development and erythroid differentiation. Exp Hematol. 2005;33:259–271.

    Article  CAS  PubMed  Google Scholar 

  12. Schechter AN. Hemoglobin research and the origins of molecular medicine. Blood. 2008;112:3927–3938.

    Article  CAS  PubMed  Google Scholar 

  13. Hardison RC, Chui DH, Riemer C, et al. Databases of human hemoglobin variants and other resources at the globin gene server. Hemoglobin. 2001;25:183–193.

    Article  CAS  PubMed  Google Scholar 

  14. Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004;32:D537–D541.

    Article  CAS  PubMed  Google Scholar 

  15. Allen SJ, O’Donnell A, Alexander ND, et al. alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci USA. 1997;94:14736–14741.

    Article  CAS  PubMed  Google Scholar 

  16. May J, Evans JA, Timmann C, et al. Hemoglobin variants and disease manifestations in severe falciparum malaria. JAMA. 2007;297:2220–2226.

    Article  CAS  PubMed  Google Scholar 

  17. Mockenhaupt FP, Ehrhardt S, Gellert S, et al. Alpha(+)-thalassemia protects African children from severe malaria. Blood. 2004;104:2003–2006.

    Article  CAS  PubMed  Google Scholar 

  18. Wambua S, Mwangi TW, Kortok M, et al. The effect of alpha+-thalassaemia on the incidence of malaria and other diseases in children living on the coast of Kenya. PLoS Med. 2006;3:e158.

    Article  PubMed  Google Scholar 

  19. Williams TN, Wambua S, Uyoga S, et al. Both heterozygous and homozygous alpha+ thalassemias protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya. Blood. 2005;106:368–371.

    Article  CAS  PubMed  Google Scholar 

  20. Clegg JB, Weatherall DJ. Thalassemia and malaria: new insights into an old problem. Proc Assoc Am Physicians. 1999;111:278–282.

    Article  CAS  PubMed  Google Scholar 

  21. Williams TN, Maitland K, Bennett S, et al. High incidence of malaria in alpha-thalassaemic children. Nature. 1996;383:522–525.

    Article  CAS  PubMed  Google Scholar 

  22. Pattanapanyasat K, Yongvanitchit K, Tongtawe P, et al. Impairment of Plasmodium falciparum growth in thalassemic red blood cells: further evidence by using biotin labeling and flow cytometry. Blood. 1999;93:3116–3119.

    CAS  PubMed  Google Scholar 

  23. Willcox M, Bjorkman A, Brohult J. Falciparum malaria and beta-thalassaemia trait in northern Liberia. Ann Trop Med Parasitol. 1983;77:335–347.

    CAS  PubMed  Google Scholar 

  24. Chui DH, Cunningham MJ, Luo HY, Wolfe LC, Neufeld EJ, Steinberg MH. Screening and counseling for thalassemia. Blood. 2006;107:1735–1737.

    Article  CAS  PubMed  Google Scholar 

  25. Lorey F, Cunningham G. Impact of Asian immigration on thalassemia in California. Ann N Y Acad Sci. 1998;850:442–445.

    Article  CAS  PubMed  Google Scholar 

  26. Luo HY, Boudreaux J, Steinberg MH, Chui DH. Patients with thalassemia in the United States. Blood. 2005;105:4896–4897.

    Article  CAS  PubMed  Google Scholar 

  27. Rees DC, Styles L, Vichinsky EP, Clegg JB, Weatherall DJ. The hemoglobin E syndromes. Ann N Y Acad Sci. 1998;850:334–343.

    Article  CAS  PubMed  Google Scholar 

  28. Beris P, Darbellay R, Extermann P. Prevention of beta-thalassemia major and Hb Bart’s hydrops fetalis syndrome. Semin Hematol. 1995;32:244–261.

    CAS  PubMed  Google Scholar 

  29. Cao A, Galanello R, Rosatelli MC, Argiolu F, De Virgiliis S. Clinical experience of management of thalassemia: the Sardinian experience. Semin Hematol. 1996;33:66–75.

    CAS  PubMed  Google Scholar 

  30. Liao C, Mo QH, Li J, et al. Carrier screening for alpha- and beta-thalassemia in pregnancy: the results of an 11–year prospective program in Guangzhou Maternal and Neonatal hospital. Prenat Diagn. 2005;25:163–171.

    Article  CAS  PubMed  Google Scholar 

  31. Kazazian HH Jr. The thalassemia syndromes: molecular basis and prenatal diagnosis in 1990. Semin Hematol. 1990;27:209–228.

    CAS  PubMed  Google Scholar 

  32. Thein SL. Genetic modifiers of the beta-haemoglobinopathies. Br J Haematol. 2008;141:357–366.

    Article  CAS  PubMed  Google Scholar 

  33. Winichagoon P, Fucharoen S, Chen P, Wasi P. Genetic factors affecting clinical severity in beta-thalassemia syndromes. J Pediatr Hematol Oncol. 2000;22:573–580.

    Article  CAS  PubMed  Google Scholar 

  34. Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med. 2005;353:1135–1146.

    Article  CAS  PubMed  Google Scholar 

  35. Kazazian HH Jr, Boehm CD. Molecular basis and prenatal diagnosis of beta-thalassemia. Blood. 1988;72:1107–1116.

    CAS  PubMed  Google Scholar 

  36. Giardina PJ, Forget BG. Thalassemia Syndromes. In: Hoffman R, Benz EJ, Shattil SJ, et al., eds. Hematology: Basic Principles and Practice. 5th ed. Philadelphia: Churchill Livingstone; 2008.

    Google Scholar 

  37. Bank A. Regulation of human fetal hemoglobin: new players, new complexities. Blood. 2006;107:435–443.

    Article  CAS  PubMed  Google Scholar 

  38. Rosatelli C, Falchi AM, Scalas MT, Tuveri T, Furbetta M, Cao A. Hematological phenotype of the double heterozygous state for alpha and beta thalassemia. Hemoglobin. 1984;8:25–35.

    Article  CAS  PubMed  Google Scholar 

  39. Brittenham GM, Griffith PM, Nienhuis AW, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med. 1994;331:567–573.

    Article  CAS  PubMed  Google Scholar 

  40. Cappellini MD, Cohen A, Piga A, et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood. 2006;107:3455–3462.

    Article  CAS  PubMed  Google Scholar 

  41. Galanello R, Piga A, Forni GL, et al. Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major. Haematologica. 2006;91:1343–1351.

    CAS  PubMed  Google Scholar 

  42. Lucarelli G, Galimberti M, Giardini C, et al. Bone marrow transplantation in thalassemia. The experience of Pesaro. Ann N Y Acad Sci. 1998;850:270–275.

    Article  CAS  PubMed  Google Scholar 

  43. Lucarelli G, Gaziev J. Advances in the allogeneic transplantation for thalassemia. Blood Rev. 2008;22:53–63.

    Article  PubMed  Google Scholar 

  44. Sodani P, Gaziev D, Polchi P, et al. New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. Blood. 2004;104:1201–1203.

    Article  CAS  PubMed  Google Scholar 

  45. Cao A, Saba L, Galanello R, Rosatelli MC. Molecular diagnosis and carrier screening for beta thalassemia. JAMA. 1997;278:1273–1277.

    Article  CAS  PubMed  Google Scholar 

  46. Modell B, Bulyzhenkov V. Distribution and control of some genetic disorders. World Health Stat Q. 1988;41:209–218.

    CAS  PubMed  Google Scholar 

  47. Arcasoy MO, Gallagher PG. Molecular diagnosis of hemoglobinopathies and other red blood cell disorders. Semin Hematol. 1999;36:328–339.

    CAS  PubMed  Google Scholar 

  48. Sutcharitchan P, Embury SH. Advances in molecular diagnosis of inherited hemoglobin disorders. Curr Opin Hematol. 1996;3:131–138.

    Article  CAS  PubMed  Google Scholar 

  49. Chiu RW, Lau TK, Leung TN, Chow KC, Chui DH, Lo YM. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet. 2002;360:998–1000.

    Article  PubMed  Google Scholar 

  50. Chotivanich K, Udomsangpetch R, Pattanapanyasat K, et al. Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P falciparum malaria. Blood. 2002;100:1172–1176.

    CAS  PubMed  Google Scholar 

  51. Olivieri NF, Muraca GM, O’Donnell A, Premawardhena A, Fisher C, Weatherall DJ. Studies in haemoglobin E beta-thalassaemia. Br J Haematol. 2008;141:388–397.

    Article  CAS  PubMed  Google Scholar 

  52. Weatherall DJ. Introduction to the problem of hemoglobin E-beta thalassemia. J Pediatr Hematol Oncol. 2000;22:551.

    Article  CAS  PubMed  Google Scholar 

  53. Bunn HF, Forget BG. Hemoglobin: Molecular, Genetic and Clinical Aspects. Philadelphis: W. B. Saunders; 1986.

    Google Scholar 

  54. Balduini CL, Pecci A, Loffredo G, et al. Effects of the R216Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis. Thromb Haemost. 2004;91:129–140.

    CAS  PubMed  Google Scholar 

  55. Yu C, Niakan KK, Matsushita M, Stamatoyannopoulos G, Orkin SH, Raskind WH. X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. Blood. 2002;100:2040–2045.

    Article  CAS  PubMed  Google Scholar 

  56. Thompson AR, Wood WG, Stamatoyannopoulos G. X-linked syndrome of platelet dysfunction, thrombocytopenia, and imbalanced globin chain synthesis with hemolysis. Blood. 1977;50:303–316.

    CAS  PubMed  Google Scholar 

  57. Leung WC, Leung KY, Lau ET, Tang MH, Chan V. Alpha-thalassaemia. Semin Fetal Neonatal Med. 2008;13:215–222.

    Article  CAS  PubMed  Google Scholar 

  58. Weatherall DJ. The thalassemias. In: Stamatoyannopoulos G, Majerus PW, Perlmutter RM, Varmus H, eds. The Molecular Basis of Blood Disease. 3rd ed. Philadelphia: W. B. Saunders; 2001.

    Google Scholar 

  59. Lafferty JD, Crowther MA, Waye JS, Chui DH. A reliable screening test to identify adult carriers of the (–SEA) alpha zero-thalassemia deletion. Detection of embryonic zeta-globin chains by enzyme-linked immunosorbent assay. Am J Clin Pathol. 2000;114:927–931.

    Article  CAS  PubMed  Google Scholar 

  60. Ma SK, Ma V, Chan AY, Chan LC, Chui DH. Routine screening of (–(SEA)) alpha-thalassemia deletion by an enzyme-linked immunosorbent assay for embryonic zeta-globin chains. Acta Haematol. 2002;108:8–12.

    Article  CAS  PubMed  Google Scholar 

  61. Chui DH, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood. 2003;101:791–800.

    Article  CAS  PubMed  Google Scholar 

  62. Chen FE, Ooi C, Ha SY, et al. Genetic and clinical features of hemoglobin H disease in Chinese patients. N Engl J Med. 2000;343:544–550.

    Article  CAS  PubMed  Google Scholar 

  63. Lau ET, Kwok YK, Luo HY, et al. Simple non-invasive prenatal detection of Hb Bart’s disease by analysis of fetal erythrocytes in maternal blood. Prenat Diagn. 2005;25:123–128.

    Article  PubMed  Google Scholar 

  64. Winichagoon P, Sithongdee S, Kanokpongsakdi S, Tantisirin P, Bernini LF, Fucharoen S. Noninvasive prenatal diagnosis for hemoglobin Bart’s hydrops fetalis. Int J Hematol. 2005;81:396–399.

    Article  CAS  PubMed  Google Scholar 

  65. Wilkie AO, Buckle VJ, Harris PC, et al. Clinical features and molecular analysis of the alpha thalassemia/mental retardation syndromes. I. Cases due to deletions involving chromosome band 16p13.3. Am J Hum Genet. 1990;46:1112–1126.

    CAS  PubMed  Google Scholar 

  66. Gibbons RJ, Pellagatti A, Garrick D, et al. Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS). Nat Genet. 2003;34:446–449.

    Article  CAS  PubMed  Google Scholar 

  67. Wada T, Kubota T, Fukushima Y, Saitoh S. Molecular genetic study of Japanese patients with X-linked alpha-thalassemia/mental retardation syndrome (ATR-X). Am J Med Genet. 2000;94:242–248.

    Article  CAS  PubMed  Google Scholar 

  68. Wilkie AO, Zeitlin HC, Lindenbaum RH, et al. Clinical features and molecular analysis of the alpha thalassemia/mental retardation syndromes. II. Cases without detectable abnormality of the alpha globin complex. Am J Hum Genet. 1990;46:1127–1140.

    CAS  PubMed  Google Scholar 

  69. Steensma DP, Gibbons RJ, Higgs DR. Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies. Blood. 2005;105:443–452.

    Article  CAS  PubMed  Google Scholar 

  70. Steensma DP, Viprakasit V, Hendrick A, et al. Deletion of the alpha-globin gene cluster as a cause of acquired alpha-thalassemia in myelodysplastic syndrome. Blood. 2004;103:1518–1520.

    Article  CAS  PubMed  Google Scholar 

  71. Steensma DP, Higgs DR, Fisher CA, Gibbons RJ. Acquired somatic ATRX mutations in myelodysplastic syndrome associated with alpha thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations. Blood. 2004;103:2019–2026.

    Article  CAS  PubMed  Google Scholar 

  72. Derry S, Wood WG, Pippard M, et al. Hematologic and biosynthetic studies in homozygous hemoglobin Constant Spring. J Clin Invest. 1984;73:1673–1682.

    Article  CAS  PubMed  Google Scholar 

  73. Clegg JB, Weatherall DJ. Hemoglobin Constant Spring, and unusual alpha-chain variant involved in the etiology of hemoglobin H disease. Ann N Y Acad Sci. 1974;232:168–178.

    Article  CAS  PubMed  Google Scholar 

  74. Frenette PS, Atweh GF. Sickle cell disease: old discoveries, new concepts, and future promise. J Clin Invest. 2007;117:850–858.

    Article  CAS  PubMed  Google Scholar 

  75. Aidoo M, Terlouw DJ, Kolczak MS, et al. Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet. 2002;359:1311–1312.

    Article  CAS  PubMed  Google Scholar 

  76. Ayi K, Turrini F, Piga A, Arese P. Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait. Blood. 2004;104:3364–3371.

    Article  CAS  PubMed  Google Scholar 

  77. Cholera R, Brittain NJ, Gillrie MR, et al. Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin. Proc Natl Acad Sci USA. 2008;105:991–996.

    Article  CAS  PubMed  Google Scholar 

  78. Williams TN, Mwangi TW, Roberts DJ, et al. An immune basis for malaria protection by the sickle cell trait. PLoS Med. 2005;2:e128.

    Article  PubMed  Google Scholar 

  79. Serving the family from birth to the medical home. A report from the Newborn Screening Task Force convened in Washington DC, May 10–11, 1999. Pediatrics. 2000;106:383–427.

    Google Scholar 

  80. Motulsky AG. Frequency of sickling disorders in U.S. blacks. N Engl J Med. 1973;288:31–33.

    Article  CAS  PubMed  Google Scholar 

  81. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997;337:762–769.

    Article  CAS  PubMed  Google Scholar 

  82. Nagel RL, Platt OS. General pathophysiology of sickle cell anemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, eds. Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management. Cambridge: Cambridge University Press; 2001.

    Google Scholar 

  83. Steinberg MH. Predicting clinical severity in sickle cell anaemia. Br J Haematol. 2005;129:465–481.

    Article  CAS  PubMed  Google Scholar 

  84. Saunthararajah Y, Vichinsky EP. Sickle cell disease – clinical features and management. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE, eds. Hematolgy: Basic Principles and Practice. Philadelphis: Churchill Livingstone; 2008.

    Google Scholar 

  85. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med. 1986;314:1593–1599.

    Article  CAS  PubMed  Google Scholar 

  86. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325:11–16.

    Article  CAS  PubMed  Google Scholar 

  87. Adams RJ, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005;353:2769–2778.

    Article  CAS  PubMed  Google Scholar 

  88. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339:5–11.

    Article  CAS  PubMed  Google Scholar 

  89. Chang Milbauer L, Wei P, Enenstein J, et al. Genetic endothelial systems biology of sickle stroke risk. Blood. 2008;111:3872–3879.

    Article  PubMed  CAS  Google Scholar 

  90. Sebastiani P, Ramoni MF, Nolan V, Baldwin CT, Steinberg MH. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet. 2005;37:435–440.

    Article  CAS  PubMed  Google Scholar 

  91. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91:288–294.

    CAS  PubMed  Google Scholar 

  92. Qureshi N, Lubin B, Walters MC. The prevention and management of stroke in sickle cell anaemia. Expert Opin Biol Ther. 2006;6:1087–1098.

    Article  CAS  PubMed  Google Scholar 

  93. Scothorn DJ, Price C, Schwartz D, et al. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr. 2002;140:348–354.

    Article  PubMed  Google Scholar 

  94. Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood. 1994;84:643–649.

    CAS  PubMed  Google Scholar 

  95. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000;342:1855–1865.

    Article  CAS  PubMed  Google Scholar 

  96. Neumayr L, Koshy M, Haberkern C, et al. Surgery in patients with hemoglobin SC disease. Preoperative Transfusion in Sickle Cell Disease Study Group. Am J Hematol. 1998;57:101–108.

    Article  CAS  PubMed  Google Scholar 

  97. Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995;333:206–213.

    Article  CAS  PubMed  Google Scholar 

  98. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639–1644.

    Article  CAS  PubMed  Google Scholar 

  99. Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C. Outcome of sickle cell anemia: a 4–decade observational study of 1056 patients. Medicine (Baltimore). 2005;84:363–376.

    Article  Google Scholar 

  100. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood. 2004;103:4023–4027.

    Article  CAS  PubMed  Google Scholar 

  101. Gladwin MT, Vichinsky E. Pulmonary complications of sickle cell disease. N Engl J Med. 2008;359:2254–2265.

    Article  CAS  PubMed  Google Scholar 

  102. Steinberg MH, Barton F, Castro O, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA. 2003;289:1645–1651.

    Article  CAS  PubMed  Google Scholar 

  103. Brawley OW, Cornelius LJ, Edwards LR, et al. National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease. Ann Intern Med. 2008;148:932–938.

    PubMed  Google Scholar 

  104. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332:1317–1322.

    Article  CAS  PubMed  Google Scholar 

  105. Lanzkron S, Strouse JJ, Wilson R, et al. Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med. 2008;148:939–955.

    PubMed  Google Scholar 

  106. Steinberg MH, Lu ZH, Barton FB, Terrin ML, Charache S, Dover GJ. Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea. Blood. 1997;89:1078–1088.

    CAS  PubMed  Google Scholar 

  107. Vichinsky E, Onyekwere O, Porter J, et al. A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Haematol. 2007;136:501–508.

    Article  CAS  PubMed  Google Scholar 

  108. Bernaudin F, Souillet G, Vannier JP, et al. Bone marrow transplantation (BMT) in 14 children with severe sickle cell disease (SCD): the French experience. GEGMO. Bone Marrow Transplant. 1993;12 Suppl 1:118–121.

    Google Scholar 

  109. Locatelli F, Rocha V, Reed W, et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood. 2003;101:2137–2143.

    Article  CAS  PubMed  Google Scholar 

  110. Modiano D, Luoni G, Sirima BS, et al. Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature. 2001;414:305–308.

    Article  CAS  PubMed  Google Scholar 

  111. Powars DR, Hiti A, Ramicone E, Johnson C, Chan L. Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors. Am J Hematol. 2002;70:206–215.

    Article  CAS  PubMed  Google Scholar 

  112. Fleming AF. The presentation, management and prevention of crisis in sickle cell disease in Africa. Blood Rev. 1989;3:18–28.

    Article  CAS  PubMed  Google Scholar 

  113. Steinberg MH, Embury SH. Alpha-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene. Blood. 1986;68:985–990.

    CAS  PubMed  Google Scholar 

  114. National Heart, Lung and Blood Institute. The Management of Sickle Cell Disease. Bethesda, MD: NIH; 2002.

    Google Scholar 

  115. Kelleher JF Jr, Park JO, Kim HC, Schroeder WA. Life-threatening complications in a child with hemoglobin SD-Los Angeles disease. Hemoglobin. 1984;8:203–213.

    Article  PubMed  Google Scholar 

  116. Masiello D, Heeney MM, Adewoye AH, et al. Hemoglobin SE disease: a concise review. Am J Hematol. 2007;82:643–649.

    Article  CAS  PubMed  Google Scholar 

  117. O’Reilly RA. A kindred with hemoglobin Lepore. JAMA. 1976;236:478–480.

    Article  PubMed  Google Scholar 

  118. Stevens MC, Lehmann H, Mason KP, Serjeant BE, Serjeant GR. Sickle cell-Hb Lepore Boston syndrome. Uncommon differential diagnosis to homozygous sickle cell disease. Am J Dis Child. 1982;136:19–22.

    CAS  PubMed  Google Scholar 

  119. Zimmerman SA, O’Branski EE, Rosse WF, Ware RE. Hemoglobin S/O(Arab): thirteen new cases and review of the literature. Am J Hematol. 1999;60:279–284.

    Article  CAS  PubMed  Google Scholar 

  120. Forget BG. Molecular basis of hereditary persistence of fetal hemoglobin. Ann N Y Acad Sci. 1998;850:38–44.

    Article  CAS  PubMed  Google Scholar 

  121. Chang YC, Smith KD, Moore RD, Serjeant GR, Dover GJ. An analysis of fetal hemoglobin variation in sickle cell disease: the relative contributions of the X-linked factor, beta-globin haplotypes, alpha-globin gene number, gender, and age. Blood. 1995;85:1111–1117.

    CAS  PubMed  Google Scholar 

  122. Craig JE, Rochette J, Fisher CA, et al. Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach. Nat Genet. 1996;12:58–64.

    Article  CAS  PubMed  Google Scholar 

  123. Craig JE, Rochette J, Sampietro M, et al. Genetic heterogeneity in heterocellular hereditary persistence of fetal hemoglobin. Blood. 1997;90:428–434.

    CAS  PubMed  Google Scholar 

  124. Miller DR, Weed RI, Stamatoyannopoulos G, Yoshida A. Hemoglobin Koln disease occurring as a fresh mutation: erythrocyte metabolism and survival. Blood. 1971;38:715–729.

    CAS  PubMed  Google Scholar 

  125. Charache S, Weatherall DJ, Clegg JB. Polycythemia associated with a hemoglobinopathy. J Clin Invest. 1966;45:813–822.

    Article  CAS  PubMed  Google Scholar 

  126. Reissmann KR, Ruth WE, Nomura T. A human hemoglobin with lowered oxygen affinity and impaired heme-heme interactions. J Clin Invest. 1961;40:1826–1833.

    Article  CAS  PubMed  Google Scholar 

  127. Benz EJ, Ebert BL. Hemoglobin variants associated with hemolytic anemia, altered oxygen affinity and methemoglobinemias. In: Hoffman R, Benz EJ, Shattil SJ, et al., eds. Hematolgy: Basic Principles and Practice. 5th ed. Philadephia: Churchill Livingstone; 2008.

    Google Scholar 

  128. Maran J, Guan Y, Ou CN, Prchal JT. Heterogeneity of the molecular biology of methemoglobinemia: a study of eight consecutive patients. Haematologica. 2005;90:687–689.

    CAS  PubMed  Google Scholar 

  129. Gerald PS, Efron ML. Chemical studies of several varieties of Hb M. Proc Natl Acad Sci USA. 1961;47:1758–1767.

    Article  CAS  PubMed  Google Scholar 

  130. Ranney HM, Nagel RL, Heller P, Udem L. Oxygen equilibrium of hemoglobin M-Hyde Park. Biochim Biophys Acta. 1968;160:112–115.

    CAS  PubMed  Google Scholar 

  131. Ash-Bernal R, Wise R, Wright SM. Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals. Medicine (Baltimore). 2004;83:265–273.

    Article  Google Scholar 

  132. The laboratory diagnosis of haemoglobinopathies. Br J Haematol. 1998;101:783–792.

    Google Scholar 

  133. ACOG Practice Bulletin No. 78: hemoglobinopathies in pregnancy. Obstet Gynecol. 2007;109:229–237.

    Google Scholar 

  134. Trent RJ, Webster B, Bowden DK, et al. Complex phenotypes in the haemoglobinopathies: recommendations on screening and DNA testing. Pathology. 2006;38:507–519.

    Article  CAS  PubMed  Google Scholar 

  135. Clark BE, Thein SL. Molecular diagnosis of haemoglobin disorders. Clin Lab Haematol. 2004;26:159–176.

    Article  CAS  PubMed  Google Scholar 

  136. Eber S, Lux SE. Hereditary spherocytosis – defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin Hematol. 2004;41:118–141.

    Article  CAS  PubMed  Google Scholar 

  137. Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet. 2008;372:1411–1426.

    Article  CAS  PubMed  Google Scholar 

  138. Mohandas N, Chasis JA. Red blood cell deformability, membrane material properties and shape: regulation by transmembrane, skeletal and cytosolic proteins and lipids. Semin Hematol. 1993;30:171–192.

    CAS  PubMed  Google Scholar 

  139. Lusher JM, Barnhart MI. The role of the spleen in the pathoophysiology of hereditary spherocytosis and hereditary elliptocytosis. Am J Pediatr Hematol Oncol. 1980;2:31.

    Google Scholar 

  140. Iolascon A, Avvisati RA. Genotype/phenotype correlation in hereditary spherocytosis. Haematologica. 2008;93:1283–1288.

    Article  CAS  PubMed  Google Scholar 

  141. Cynober T, Mohandas N, Tchernia G. Red cell abnormalities in hereditary spherocytosis: relevance to diagnosis and understanding of the variable expression of clinical severity. J Lab Clin Med. 1996;128:259–269.

    Article  CAS  PubMed  Google Scholar 

  142. Michaels LA, Cohen AR, Zhao H, Raphael RI, Manno CS. Screening for hereditary spherocytosis by use of automated erythrocyte indexes. J Pediatr. 1997;130:957–960.

    Article  CAS  PubMed  Google Scholar 

  143. King MJ, Smythe JS, Mushens R. Eosin-5–maleimide binding to band 3 and Rh-related proteins forms the basis of a screening test for hereditary spherocytosis. Br J Haematol. 2004;124:106–113.

    Article  CAS  PubMed  Google Scholar 

  144. King MJ, Telfer P, MacKinnon H, et al. Using the eosin-5–maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis. Cytometry B Clin Cytom. 2008;74:244–250.

    PubMed  Google Scholar 

  145. Mariani M, Barcellini W, Vercellati C, et al. Clinical and hematologic features of 300 patients affected by hereditary spherocytosis grouped according to the type of the membrane protein defect. Haematologica. 2008;93:1310–1317.

    Article  CAS  PubMed  Google Scholar 

  146. An X, Mohandas N. Disorders of red cell membrane. Br J Haematol. 2008;141(3):367–375.

    CAS  PubMed  Google Scholar 

  147. Economou M, Tsatra I, Athanassiou-Metaxa M. Simultaneous presence of Gilbert syndrome and hereditary spherocytosis: interaction in the pathogenesis of hyperbilirubinemia and gallstone formation. Pediatr Hematol Oncol. 2003;20:493–495.

    PubMed  Google Scholar 

  148. Young NS. Hematologic manifestations and diagnosis of parvovirus B19 infections. Clin Adv Hematol Oncol. 2006;4:908–910.

    PubMed  Google Scholar 

  149. Tracy ET, Rice HE. Partial splenectomy for hereditary spherocytosis. Pediatr Clin North Am. 2008;55:503–519.

    Article  PubMed  Google Scholar 

  150. Hayag-Barin JE, Smith RE, Tucker FC Jr. Hereditary spherocytosis, thrombocytosis, and chronic pulmonary emboli: a case report and review of the literature. Am J Hematol. 1998;57:82–84.

    Article  CAS  PubMed  Google Scholar 

  151. Jardine DL, Laing AD. Delayed pulmonary hypertension following splenectomy for congenital spherocytosis. Intern Med J. 2004;34:214–216.

    Article  CAS  PubMed  Google Scholar 

  152. Schilling RF, Gangnon RE, Traver MI. Delayed adverse vascular events after splenectomy in hereditary spherocytosis. J Thromb Haemost. 2008;6:1289–1295.

    Article  CAS  PubMed  Google Scholar 

  153. Bolton-Maggs PH, Stevens RF, Dodd NJ, Lamont G, Tittensor P, King MJ. Guidelines for the diagnosis and management of hereditary spherocytosis. Br J Haematol. 2004;126:455–474.

    Article  CAS  PubMed  Google Scholar 

  154. Davidson RN, Wall RA. Prevention and management of infections in patients without a spleen. Clin Microbiol Infect. 2001;7:657–660.

    Article  CAS  PubMed  Google Scholar 

  155. Kaplinsky C, Spirer Z. Post-splenectomy antibiotic prophylaxis – unfinished story: to treat or not to treat? Pediatr Blood Cancer. 2006;47:740–741.

    Article  PubMed  Google Scholar 

  156. Dhermy D, Garbarz M, Lecomte MC, et al. Hereditary elliptocytosis: clinical, morphological and biochemical studies of 38 cases. Nouv Rev Fr Hematol. 1986;28:129–140.

    CAS  PubMed  Google Scholar 

  157. Gallagher PG. Hereditary elliptocytosis: spectrin and protein 4.1R. Semin Hematol. 2004;41:142–164.

    Article  CAS  PubMed  Google Scholar 

  158. Dhermy D, Schrevel J, Lecomte MC. Spectrin-based skeleton in red blood cells and malaria. Curr Opin Hematol. 2007;14:198–202.

    Article  CAS  PubMed  Google Scholar 

  159. Zarkowsky HS, Mohandas N, Speaker CB, Shohet SB. A congenital haemolytic anaemia with thermal sensitivity of the erythrocyte membrane. Br J Haematol. 1975;29:537–543.

    Article  CAS  PubMed  Google Scholar 

  160. Wilmotte R, Marechal J, Morle L, et al. Low expression allele alpha LELY of red cell spectrin is associated with mutations in exon 40 (alpha V/41 polymorphism) and intron 45 and with partial skipping of exon 46. J Clin Invest. 1993;91:2091–2096.

    Article  CAS  PubMed  Google Scholar 

  161. Bruce LJ. Red cell membrane transport abnormalities. Curr Opin Hematol. 2008;15:184–190.

    Article  CAS  PubMed  Google Scholar 

  162. Delaunay J. The hereditary stomatocytoses: genetic disorders of the red cell membrane permeability to monovalent cations. Semin Hematol. 2004;41:165–172.

    Article  PubMed  Google Scholar 

  163. Carella M, Stewart G, Ajetunmobi JF, et al. Genomewide search for dehydrated hereditary stomatocytosis (hereditary xerocytosis): mapping of locus to chromosome 16 (16q23–qter). Am J Hum Genet. 1998;63:810–816.

    Article  CAS  PubMed  Google Scholar 

  164. Iolascon A, Stewart GW, Ajetunmobi JF, et al. Familial pseudohyperkalemia maps to the same locus as dehydrated hereditary stomatocytosis (hereditary xerocytosis). Blood. 1999;93:3120–3123.

    CAS  PubMed  Google Scholar 

  165. Hooper AJ, van Bockxmeer FM, Burnett JR. Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism. Crit Rev Clin Lab Sci. 2005;42:515–545.

    Article  CAS  PubMed  Google Scholar 

  166. Tarugi P, Averna M, Di Leo E, et al. Molecular diagnosis of hypobetalipoproteinemia: an ENID review. Atherosclerosis. 2007;195(2):e19–e27.

    Article  CAS  PubMed  Google Scholar 

  167. Jung HH, Hergersberg M, Kneifel S, et al. McLeod syndrome: a novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findings. Ann Neurol. 2001;49:384–392.

    Article  CAS  PubMed  Google Scholar 

  168. Peng J, Redman CM, Wu X, et al. Insights into extensive deletions around the XK locus associated with McLeod phenotype and characterization of two novel cases. Gene. 2007;392:142–150.

    Article  CAS  PubMed  Google Scholar 

  169. Walker RH, Jung HH, Dobson-Stone C, et al. Neurologic phenotypes associated with acanthocytosis. Neurology. 2007;68:92–98.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology, Department of Medicine, Duke University Medical Center, Durham, NC, USA

    Murat O. Arcasoy MD, FACP

  2. Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA

    Patrick G. Gallagher MD

Authors
  1. Murat O. Arcasoy MD, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrick G. Gallagher MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dept. Pathology & Laboratory Medicine, University of North Carolina, Chapel Hill, 27599-7525, USA

    Cherie H. Dunphy

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Arcasoy, M.O., Gallagher, P.G. (2010). Molecular Pathology of Hemoglobin and Erythrocyte Membrane Disorders. In: Dunphy, C. (eds) Molecular Pathology of Hematolymphoid Diseases. Molecular Pathology Library, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-5698-9_37

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-5698-9_37

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-5697-2

  • Online ISBN: 978-1-4419-5698-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation